Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03114228
Title An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries CAN

Facility Status City State Zip Country Details
Novartis Investigative Site Hamilton Ontario L8V 1C3 Canada Details
Novartis Investigative Site Montreal Quebec H1T 2M4 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field